tetraarsenic tetrasulfide has been researched along with arsenic in 12 studies
| Studies (tetraarsenic tetrasulfide) | Trials (tetraarsenic tetrasulfide) | Recent Studies (post-2010) (tetraarsenic tetrasulfide) | Studies (arsenic) | Trials (arsenic) | Recent Studies (post-2010) (arsenic) |
|---|---|---|---|---|---|
| 13 | 2 | 6 | 27,806 | 280 | 13,049 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dang, H; He, Q; Hong, B; Liu, H; Lu, DP; Qiu, JY; Shi, HL; Shi, Y | 1 |
| Jiang, B; Liu, KY; Lu, DP; Lu, XJ; Shen, JC | 1 |
| Jiang, B; Li, GX; Lu, DP; Qin, XY | 1 |
| Du, JW; Fang, BJ; Gao, QL; Hu, JY; Jiang, DX; Li, YF; Lin, QD; Liu, YY; Song, YP; Wang, P; Wei, XD; Yue, H; Zhang, LN; Zhang, YL; Zhu, XH | 1 |
| Chen, W; He, P; Qi, J; Wang, H; Wang, X; Zhang, M | 1 |
| Jovanovski, G; Makreski, P; Naumov, P; Petrusevski, G; Runcevski, T | 1 |
| Huang, H; Mu, Z; Qiao, Z; Shan, S; Sun, Q; Wen, G; Xu, H; Zhang, J; Zhao, Y | 1 |
| Chen, SJ; Huang, XJ; Jiang, H; Jin, J; Li, JY; Ma, J; Wang, JX; Wu, DP; Zhu, HH | 1 |
| Cheng, X; He, P; Liu, F; Liu, Y; Shi, L; Wang, Y; Zhang, M; Zhao, J; Zhou, N; Zhu, H | 1 |
| Geng, Z; Ouyang, J; Wang, S; Wang, Z; Zhou, M | 1 |
| Guo, H; Li, X; Liu, J; Ma, Q; Meng, J; Wang, C; Xu, H | 1 |
| Gong, J; Meng, J; Wang, Y; Zhang, L; Zheng, S | 1 |
2 trial(s) available for tetraarsenic tetrasulfide and arsenic
| Article | Year |
|---|---|
[Application of all-trans retinoic acid combining chemotherapy and As4S4 in the maintenance treatment of patients with acute promyelocytic leukemia].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenicals; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Sulfides; Treatment Outcome; Tretinoin | 2007 |
Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Disease-Free Survival; Drugs, Chinese Herbal; Female; Fever; Follow-Up Studies; Humans; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Liver; Maintenance Chemotherapy; Male; Middle Aged; Oxides; Remission Induction; Sulfides; Treatment Outcome; Tretinoin; Young Adult | 2013 |
10 other study(ies) available for tetraarsenic tetrasulfide and arsenic
| Article | Year |
|---|---|
[A serial study of in cytogenetic change and morphology on the tetra-arsenic tetra-sulfide treatment in untreated or recurrent acute promyelocytic leukemia].
Topics: Adult; Arsenicals; Bone Marrow; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Female; Humans; In Situ Hybridization, Fluorescence; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Recurrence; Sulfides; Translocation, Genetic | 2003 |
[Effect of the tetra-arsenic tetra-sulfide (As4S4) on the corrected QT interval in the treatment of acute promyelocytic leukemia].
Topics: Adolescent; Adult; Antineoplastic Agents; Arsenicals; Electrocardiography; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Sulfides | 2004 |
[Chronic hepatic damage in acute promyelocytic leukemia patients treated with tetra-arsenic tetra-sulfide].
Topics: Adolescent; Adult; Aged; Arsenicals; Collagen Type IV; Fatty Liver; Female; Fibrosis; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Liver; Male; Middle Aged; Sulfides; Young Adult | 2006 |
Comparative proteome study of apoptosis induced by As4S4 in retinoid acid resistant human acute promyelocytic leukemia NB4-R1 cells.
Topics: Apoptosis; Arsenicals; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Leukemia, Promyelocytic, Acute; Prohibitins; Proteomics; Signal Transduction; Sulfides; Tretinoin | 2010 |
Visualization of a discrete solid-state process with steady-state X-ray diffraction: observation of hopping of sulfur atoms in single crystals of realgar.
Topics: Arsenicals; Catalysis; Crystallography, X-Ray; Models, Molecular; Sulfides; Sulfur | 2010 |
Effects of tetra-arsenic tetra-sulfide on BXSB lupus-prone mice: a pilot study.
Topics: Animals; Antibodies, Antinuclear; Arsenic; Arsenicals; Hair; Lupus Erythematosus, Systemic; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL; Pilot Projects; Spleen; Splenomegaly; Sulfides | 2013 |
Tetra-arsenic tetra-sulfide (As4S 4) promotes apoptosis in retinoid acid -resistant human acute promyelocytic leukemic NB4-R1 cells through downregulation of SET protein.
Topics: Apoptosis; Arsenicals; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Drug Resistance, Neoplasm; Histone Chaperones; Humans; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; RNA, Messenger; Sulfides; Transcription Factors; Tretinoin | 2014 |
Tetraarsenictetrasulfide and Arsenic Trioxide Exert Synergistic Effects on Induction of Apoptosis and Differentiation in Acute Promyelocytic Leukemia Cells.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Differentiation; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Oxides; Reactive Oxygen Species; Sulfides | 2015 |
Fabrication of water-soluble polymer-encapsulated As4S4 to increase oral bioavailability and chemotherapeutic efficacy in AML mice.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Arsenicals; Biological Availability; Disease Models, Animal; Female; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Liver; Male; Mice; Microscopy, Electron, Scanning; Polymers; Rats; Rats, Sprague-Dawley; Solubility; Spleen; Sulfides; Survival Analysis; Water | 2016 |
Induction of K562 Cell Apoptosis by As4S4 via Down-Regulating miR181.
Topics: Apoptosis; Arsenicals; Caspase 3; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Leukemic; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MicroRNAs; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Sulfides | 2017 |